767352-30-7 Usage
Description
(4R)-1-(Phenylmethoxy)-4-[(2,4,5-trifluorophenyl)methyl]-2-azetidinone is a chiral azetidinone compound characterized by its (4R) configuration and the presence of a phenylmethoxy and a (2,4,5-trifluorophenyl)methyl group. It belongs to the class of azetidinones, which are known for their diverse biological activities, making this compound a promising candidate for pharmaceutical applications and further research in medicinal chemistry.
Uses
Used in Pharmaceutical Industry:
(4R)-1-(Phenylmethoxy)-4-[(2,4,5-trifluorophenyl)methyl]-2-azetidinone is used as a potential pharmaceutical agent due to its unique structure and the biological activities associated with azetidinones. Its specific stereochemistry and substituents may contribute to its therapeutic effects and selectivity, warranting further investigation for the development of new drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 767352-30-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,7,3,5 and 2 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 767352-30:
(8*7)+(7*6)+(6*7)+(5*3)+(4*5)+(3*2)+(2*3)+(1*0)=187
187 % 10 = 7
So 767352-30-7 is a valid CAS Registry Number.
767352-30-7Relevant articles and documents
Synthesis method of sitagliptin
-
, (2020/05/29)
The invention discloses a synthetic method of sitagliptin. The synthesis method comprises the following steps of: carrying out a reaction on 1,3,5-trifluorophenylacetic acid as a raw material and pivaloyl chloride to convert into acyl chloride; under the
SITAGLIPTIN, SALTS AND POLYMORPHS THEREOF
-
Page/Page column 32, (2012/03/26)
The present invention relates to an improved process for preparation of Sitagliptin or pharmaceutically acceptable salts thereof. The present invention further relates to novel polymorphs of Sitagliptin salts and process for preparation thereof.
